OncoCyte Basic EPS 2014-2024 | OCX
OncoCyte basic eps from 2014 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| OncoCyte Annual Basic EPS | |
|---|---|
| 2023 | $-3.75 |
| 2022 | $-13.25 |
| 2021 | $-14.40 |
| 2020 | $-9.20 |
| 2019 | $-8.80 |
| 2018 | $-8.40 |
| 2017 | $-12.80 |
| 2016 | $-8.40 |
| 2015 | $-8.40 |
| 2014 | $-5.40 |
| 2013 | $-3.80 |
| OncoCyte Quarterly Basic EPS | |
|---|---|
| 2024-06-30 | $-0.36 |
| 2024-03-31 | $-1.13 |
| 2023-12-31 | $-2.27 |
| 2023-09-30 | $-0.81 |
| 2023-06-30 | $-1.07 |
| 2023-03-31 | $0.40 |
| 2022-12-31 | $-7.95 |
| 2022-09-30 | $-1.62 |
| 2022-06-30 | $-1.48 |
| 2022-03-31 | $-2.20 |
| 2021-12-31 | $-8.00 |
| 2021-09-30 | $-3.00 |
| 2021-06-30 | $-2.40 |
| 2021-03-31 | $-1.00 |
| 2020-12-31 | $-1.80 |
| 2020-09-30 | $-2.00 |
| 2020-06-30 | $-2.80 |
| 2020-03-31 | $-2.60 |
| 2019-12-31 | $-3.20 |
| 2019-09-30 | $-2.00 |
| 2019-06-30 | $-2.00 |
| 2019-03-31 | $-1.60 |
| 2018-12-31 | $-2.20 |
| 2018-09-30 | $-1.40 |
| 2018-06-30 | $-2.40 |
| 2018-03-31 | $-2.40 |
| 2017-12-31 | $-2.60 |
| 2017-09-30 | $-4.40 |
| 2017-06-30 | $-2.60 |
| 2017-03-31 | $-3.20 |
| 2016-12-31 | $-2.00 |
| 2016-09-30 | $-2.00 |
| 2016-06-30 | $-2.00 |
| 2016-03-31 | $-2.40 |
| 2015-12-31 | $-2.80 |
| 2015-09-30 | $-2.40 |
| 2015-06-30 | $-1.40 |
| 2015-03-31 | $-1.60 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.049B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.658B | 12.24 |
| Cencora (COR) | United States | $49.082B | 18.10 |
| DiDi Global (DIDIY) | China | $23.427B | 0.00 |
| ICON (ICLR) | Ireland | $17.504B | 15.59 |
| Natera (NTRA) | United States | $16.570B | 0.00 |
| Viatris (VTRS) | United States | $15.624B | 4.81 |
| Avantor (AVTR) | United States | $15.178B | 22.75 |
| Revvity (RVTY) | United States | $14.682B | 25.50 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.998B | 0.00 |
| Solventum (SOLV) | United States | $12.357B | 0.00 |
| Doximity (DOCS) | United States | $11.372B | 67.31 |
| Medpace Holdings (MEDP) | United States | $11.301B | 31.84 |
| Charles River Laboratories (CRL) | United States | $11.285B | 21.81 |
| HealthEquity (HQY) | United States | $8.756B | 47.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.590B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.202B | 33.53 |
| Life Times (LTH) | United States | $5.139B | 34.01 |
| Sotera Health (SHC) | United States | $4.509B | 24.12 |
| Organon (OGN) | United States | $4.144B | 4.18 |
| Surgery Partners (SGRY) | United States | $3.996B | 44.27 |
| BrightSpring Health Services (BTSG) | United States | $3.489B | 74.22 |
| PACS (PACS) | United States | $3.347B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.580B | 0.00 |
| Concentras Parent (CON) | United States | $2.505B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.471B | 0.00 |
| Premier (PINC) | United States | $2.314B | 11.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.016B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.689B | 0.00 |
| Progyny (PGNY) | United States | $1.540B | 27.08 |
| Pediatrix Medical (MD) | United States | $1.371B | 13.41 |
| Establishment Labs Holdings (ESTA) | $1.266B | 0.00 | |
| CareDx (CDNA) | United States | $1.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.058B | 7.16 |
| Embecta (EMBC) | United States | $0.910B | 6.07 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.809B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.723B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| DocGo (DCGO) | United States | $0.411B | 15.46 |
| Enhabit (EHAB) | United States | $0.403B | 34.83 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.248B | 0.00 |
| ModivCare (MODV) | United States | $0.231B | 12.54 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Biodesix (BDSX) | United States | $0.205B | 0.00 |
| Nutex Health (NUTX) | United States | $0.152B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| So-Young (SY) | China | $0.088B | 21.28 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.10 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |